Erica Landgraf
Family · Greenfield, WINPI 1265093348
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,838 of the $14,840 with a category attached, or 79.8%. 29 manufacturers reported payments, led by AstraZeneca at 28.6% of the total. Among family clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $31.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- GSK$2K
- Sanofi$2K
- Genentech USA, Inc.$1K
- Amgen$687
- Optinose US, Inc.$637
- plus $4K from 23 others
What the payments were for
- Consulting fees$8756%
- Travel & lodging$1,55410%
- Food & beverage$11,83880%
- Education$5744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 73 | $4,246 |
| GSK | 86 | $2,036 |
| Sanofi | 69 | $1,740 |
| Genentech USA, Inc. | 6 | $1,212 |
| Amgen | 40 | $687 |
| Optinose US, Inc. | 42 | $637 |
| Teva Pharmaceuticals USA, Inc. | 26 | $579 |
| Regeneron Healthcare Solutions, Inc. | 15 | $547 |
| Novartis | 11 | $531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $431 |
| Covis Pharma GmbH | 18 | $389 |
| Alk-abello, Inc | 15 | $361 |
| Pfizer | 15 | $304 |
| Sanofi-aventis U.S. LLC | 3 | $247 |
| Boehringer Ingelheim | 7 | $126 |
| Grifols USA, LLC | 7 | $121 |
| Genentech, Inc. | 1 | $112 |
| Kyowa Kirin, Inc. | 1 | $97 |
| Kaleo, Inc. | 4 | $80 |
| Verona Pharma, Inc. | 3 | $71 |
| Hospira, Inc. | 4 | $68 |
| Mylan Specialty L.p. | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| Viatris Specialty LLC | 1 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| CSL Behring | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Biocryst US Sales Co., LLC | 1 | $18 |
| USWM, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,840 in reported general payments places this provider in the 95th percentile of 1,273 family providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $23,544 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $14,201 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $9,432 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,157 |
| Arnuity ElliptaFluticasone Furoate | 23 | $6,052 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $6,008 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $4,650 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $985 |
| Fluticasone Propionate | 40 | $752 |
| Omeprazole | 15 | $323 |
| Azelastine Hcl | 12 | $303 |
| Ipratropium Bromide | 12 | $283 |
| Montelukast Sodium | 11 | $49 |
| Prednisone | 15 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Symbicort | $4,246 | $29,55250 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $2,036 | $26,41152 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $579 | $4,65012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,273 family providers in Wisconsin.
Other family in Greenfield
- Melissa McGuireGreenfield$5K
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.